In addition to PD-1-mediated metabolic alterations described in T cells and monocytes, in a melanoma mouse model it has been shown that PD-1 knockout reduces the accumulation of granulocyte and monocyte precursors, as well as the immunosuppressive activity of MDSCs, in part through metabolic alterations. The gene discussed is PDCD1; the disease is melanoma.